MDWD
$2.89
Mediwound Ltd Ord Sh
($.11)
(3.67%)
MDWD
Earnings Whisper ®
N/A
4th Quarter December 2021
Consensus:  ($0.16)
Revenue:  $5.65 Mil
Tuesday
Feb 15
7:00 AM ET
Score
Grade
Tweet Share Watch
Tweet Share Watch
Latest EPS
Tuesday, November 16, 2021

What do you expect when MDWD reports earnings?
Beat
Meet
Miss

Where is MDWD's stock price going from here?
Up
Flat
Down
Stock chart of MDWD
Analysts
Summary of analysts' recommendations for MDWD
Score
Grade
Pivots
Resistance
$3.26
$3.16
$3.03

$2.93

Support
$2.79
$2.69
$2.56
Tweet
Growth
Description
MediWound Ltd. is a biotechnology niche specialty company. It is focused on developing, manufacturing and commercializing products that address unmet needs in the fields of severe burn and chronic wound management. The company is also developing NexoBrid for the removal of eschar, a dead or damaged tissue in adults with deep partial- and full-thickness thermal burns. MediWound Ltd. is headquartered in Yavne, Israel.
Peers
Vertex PharmaceuticalsMerck & Co.Ultragenyx PharmaceuticalRegeneron PharmaceuticalsBioMarin PharmaceuticalBristol-Myers SquibbEli LillyZoetisPfizerInterCept